Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Warren Olanow

Showing results (31-40 of 189) with videos related to

Pageof 19
Sort By:
Neurology|January 14, 2004
Continuous dopaminergic stimulation in early and advanced Parkinson's diseaseFabrizio Stocchi, C Warren Olanow
Neurology|January 14, 2004
COMT inhibitors in Parkinson's disease: can they prevent and/or reverse levodopa-induced motor complications?C Warren Olanow, Fabrizio Stocchi
Movement Disorders : Official Journal of the Movement Disorder Society|February 8, 2013
Obstacles to the development of a neuroprotective therapy for Parkinson's diseaseFabrizio Stocchi, C Warren Olanow
Annals of Neurology|April 1, 2003
Neuroprotection in Parkinson's disease: clinical trialsFabrizio Stocchi, C Warren Olanow
The Mount Sinai Journal of Medicine, New York|May 23, 2007
Translational experimental therapeutics: The translation of laboratory-based discovery into disease-related therapyKarl Kieburtz, C Warren Olanow
Movement Disorders : Official Journal of the Movement Disorder Society|December 20, 2015
Eldad Melamed 1942-2015: Ave atque--A memorialC Warren Olanow, Werner Poewe
The Journal of Biological Chemistry|April 5, 2008
Differential modulation of Akt/glycogen synthase kinase-3beta pathway regulates apoptotic and cytoprotective signaling responsesVenugopalan D Nair, C Warren Olanow
Movement Disorders : Official Journal of the Movement Disorder Society|December 10, 2014
The end of the termC Warren Olanow, Jose A Obeso
Neurology|September 16, 2011
Levodopa toxicity and Parkinson disease: still a need for equipoiseC Warren Olanow, Jose A Obeso
Journal of Neuropathology and Experimental Neurology|September 21, 2007
The neuropathology of manganese-induced ParkinsonismDaniel P Perl, C Warren Olanow
Pageof 19

Showing results (31-40 of 189) with videos related to

Sort By:
Pageof 19
Neurology|January 14, 2004
Continuous dopaminergic stimulation in early and advanced Parkinson's diseaseFabrizio Stocchi, C Warren Olanow
Neurology|January 14, 2004
COMT inhibitors in Parkinson's disease: can they prevent and/or reverse levodopa-induced motor complications?C Warren Olanow, Fabrizio Stocchi
Movement Disorders : Official Journal of the Movement Disorder Society|February 8, 2013
Obstacles to the development of a neuroprotective therapy for Parkinson's diseaseFabrizio Stocchi, C Warren Olanow
Annals of Neurology|April 1, 2003
Neuroprotection in Parkinson's disease: clinical trialsFabrizio Stocchi, C Warren Olanow
The Mount Sinai Journal of Medicine, New York|May 23, 2007
Translational experimental therapeutics: The translation of laboratory-based discovery into disease-related therapyKarl Kieburtz, C Warren Olanow
Movement Disorders : Official Journal of the Movement Disorder Society|December 20, 2015
Eldad Melamed 1942-2015: Ave atque--A memorialC Warren Olanow, Werner Poewe
The Journal of Biological Chemistry|April 5, 2008
Differential modulation of Akt/glycogen synthase kinase-3beta pathway regulates apoptotic and cytoprotective signaling responsesVenugopalan D Nair, C Warren Olanow
Movement Disorders : Official Journal of the Movement Disorder Society|December 10, 2014
The end of the termC Warren Olanow, Jose A Obeso
Neurology|September 16, 2011
Levodopa toxicity and Parkinson disease: still a need for equipoiseC Warren Olanow, Jose A Obeso
Journal of Neuropathology and Experimental Neurology|September 21, 2007
The neuropathology of manganese-induced ParkinsonismDaniel P Perl, C Warren Olanow
Pageof 19